News | 08 September 2023
Briefs: NATCO Pharma, Strides Pharma and Aurobindo Pharma
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
The company will develop and produce premixes for human nutrition applications
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
With All India Institute of Ayurveda as a knowledge partner and Sodexo’s culinary expertise, Aarogyum is a well-rounded offering in patient dining solutions
The generous donation includes multiple medical equipments
Marking a significant milestone in its commitment to holistic wellness
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
The cognitively operated system is a mother patent invention, first launched in India
This approval has come from the company's finished dosage form manufacturing facility
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Sets price band at ?695 to ?735 per Equity Share
Subscribe To Our Newsletter & Stay Updated
